Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMC 2864410)

Published in Carcinogenesis on February 01, 2010

Authors

Joanna Laurson1, Sadaf Khan, Rachel Chung, Karen Cross, Kenneth Raj

Author Affiliations

1: Department of Virology, The National Institute for Medical Research, The Ridgeway Mill Hill, London NW7 1AA, UK.

Articles citing this

Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (2012) 2.15

Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol (2010) 1.32

The papillomavirus E7 proteins. Virology (2013) 1.28

Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23

Human papillomavirus molecular biology and disease association. Rev Med Virol (2015) 1.09

Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol (2011) 1.04

Epigenetics of human papillomaviruses. Virology (2013) 1.00

Genomic landscape of human papillomavirus-associated cancers. Clin Cancer Res (2015) 0.99

Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer (2012) 0.90

Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One (2012) 0.88

Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS One (2015) 0.86

How virus persistence can initiate the tumorigenesis process. World J Virol (2013) 0.84

DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One (2012) 0.83

Mucosal immunity in the female genital tract, HIV/AIDS. Biomed Res Int (2014) 0.81

Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation. Cancer Sci (2015) 0.78

A B-cell targeting virus disrupts potentially protective genomic methylation patterns in lymphoid tissue by increasing global 5-hydroxymethylcytosine levels. Vet Res (2014) 0.77

Mutations in components of antiviral or microbial defense as a basis for breast cancer. Funct Integr Genomics (2013) 0.77

Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression. Invest New Drugs (2012) 0.77

The human papillomavirus E7 oncoprotein as a regulator of transcription. Virus Res (2016) 0.76

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study. Br J Cancer (2017) 0.76

Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study. Diagn Pathol (2015) 0.76

The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary. J Oncol (2010) 0.76

Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice. Sci Rep (2016) 0.75

LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter. Oncotarget (2016) 0.75

The etiologic spectrum of head and neck squamous cell carcinoma in young patients. Oncotarget (2016) 0.75

Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell Int (2013) 0.75

Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines. Iran J Basic Med Sci (2016) 0.75

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis. Proc Natl Acad Sci U S A (2016) 0.75

Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection. Sci Rep (2016) 0.75

Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses (2017) 0.75

5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells. Oncotarget (2016) 0.75

Articles cited by this

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60

The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res (2002) 6.47

Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med (1989) 5.65

A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J (1991) 5.39

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A (1991) 5.31

A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis (2007) 3.59

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst (2008) 3.32

Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med (2007) 3.05

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis (2004) 2.70

Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer (2003) 2.53

Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol (2000) 2.08

Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00

Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer (2002) 1.92

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A (2002) 1.92

Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med (1999) 1.89

Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol (2008) 1.60

The role of papillomaviruses in human cancer. Important Adv Oncol (1987) 1.60

Viral oncoproteins target the DNA methyltransferases. Oncogene (2006) 1.59

Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59

Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54

The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol (1997) 1.51

Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma. J Surg Oncol (2005) 1.50

Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci U S A (2006) 1.43

Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J (1992) 1.43

E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours. Eur J Cancer (2003) 1.42

Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther (2007) 1.42

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res (2006) 1.38

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene (2005) 1.34

Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol (1998) 1.33

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer (1994) 1.27

Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res (2007) 1.26

Langerhans' cells in human cervical epithelium: an immunohistological study. Br J Obstet Gynaecol (1983) 1.25

Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology (1994) 1.24

Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol (2005) 1.24

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol (1999) 1.21

Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol (1995) 1.19

Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol (2002) 1.19

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene (2006) 1.15

Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol (1999) 1.09

Role of cytokines in epidermal Langerhans cell migration. J Leukoc Biol (1999) 1.07

E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J Pathol (2005) 1.04

Different modes of human papillomavirus DNA replication during maintenance. J Virol (2006) 1.04

Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett (2007) 1.04

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J Virol (2003) 1.04

Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer (2002) 1.03

Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol (1983) 1.02

Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am J Pathol (2008) 1.01

HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology (2009) 0.99

Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J Clin Pathol (1988) 0.99

Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol (2005) 0.98

Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol (1986) 0.95

Cadherins and Langerhans cell immunobiology. Clin Exp Immunol (1997) 0.95

Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int Immunol (2001) 0.95

Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother (2008) 0.92

E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harb Symp Quant Biol (1994) 0.92

Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett (1997) 0.91

Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis (2008) 0.91

Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer (1992) 0.90

Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol (1999) 0.89

E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix. Gynecol Oncol (1997) 0.87

E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiology (2004) 0.87

E-cadherin expression during progression of squamous intraepithelial lesions in the uterine cervix. Eur J Gynaecol Oncol (2005) 0.86

Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol (1993) 0.86

Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology (1990) 0.85

Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol (1999) 0.84

Local immune response in persistent cervical dysplasia. Obstet Gynecol (1993) 0.83

Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers. Tumour Biol (1997) 0.83

Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch (1995) 0.83

E-cadherin and catenins in early squamous cervical carcinoma. Gynecol Oncol (2004) 0.82

Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark (2005) 0.82

Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia. BMJ (1988) 0.82

Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J Mol Med (Berl) (2001) 0.81

Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer. Eur J Gynaecol Oncol (2006) 0.81

The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Virology (2009) 0.80

Granulocyte/macrophage-colony-stimulating factor induces the migration of human epidermal Langerhans cells in vitro. Exp Dermatol (1996) 0.80

[E-cadherin expression and its clinical significance in cervical cancer]. Zhonghua Zhong Liu Za Zhi (2000) 0.77

Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features. Eur J Gynaecol Oncol (2005) 0.76

Langerhans cell population in early invasive squamous cell carcinoma of the uterine cervix. Aust N Z J Obstet Gynaecol (1989) 0.76

Articles by these authors

Notch1 functions as a tumor suppressor in mouse skin. Nat Genet (2003) 6.76

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature (2011) 6.14

The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer (2003) 4.75

A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98

Virtual reality simulator training for laparoscopic colectomy: what metrics have construct validity? Dis Colon Rectum (2014) 1.51

Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial. PLoS Med (2013) 1.32

Viral transport of DNA damage that mimics a stalled replication fork. J Virol (2005) 1.24

Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol (2002) 1.21

Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle (2007) 1.20

Large congenital mesenteric defect presenting in an adult. Saudi J Gastroenterol (2010) 1.19

How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc Natl Acad Sci U S A (2005) 1.15

Foxj1 regulates floor plate cilia architecture and modifies the response of cells to sonic hedgehog signalling. Development (2010) 1.13

Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial. BMC Pregnancy Childbirth (2012) 1.11

Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol (2003) 1.11

Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J Virol (2005) 1.10

Acute mesenteric venous thrombosis: improved outcome with early diagnosis and prompt anticoagulation therapy. Int J Surg (2009) 1.06

Knowledge, attitudes and practices around health research: the perspective of physicians-in-training in Pakistan. BMC Med Educ (2009) 1.06

Different modes of human papillomavirus DNA replication during maintenance. J Virol (2006) 1.04

Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res (2003) 1.03

Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology (2011) 1.02

Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes. J Immunol (2005) 1.01

Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage (2009) 0.98

Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression. Aging Cell (2014) 0.95

Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1--E4 protein and provides a molecular basis for its accumulation. J Virol (2008) 0.88

Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6. Cancer Res (2007) 0.88

Abortion: a major contributor to maternal ill health. J Pak Med Assoc (2005) 0.86

Polynuclear transition metal complexes with thiocarbohydrazide and dithiocarbamates. Spectrochim Acta A Mol Biomol Spectrosc (2006) 0.85

Serious and life-threatening pregnancy-related infections: opportunities to reduce the global burden. PLoS Med (2012) 0.82

Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence. PLoS One (2011) 0.81

Emerging indications for percutaneous cholecystostomy for the management of acute cholecystitis--a retrospective review. Int J Surg (2011) 0.80

Tips for developing a valid and reliable bank of multiple choice questions (MCQs). Educ Health (Abingdon) (2013) 0.80

Relationship of non-organic factors with malnutrition among children under three years of age. J Coll Physicians Surg Pak (2006) 0.79

Antibiotics in acute necrotizing pancreatitis--perspective of a developing country. J Pak Med Assoc (2010) 0.76

Quetiapine-induced galactorrhea with normal prolactin level in an adult female patient. Prim Care Companion CNS Disord (2012) 0.75

Avulsion of the flexor digitorum tendon secondary to enchondroma of the distal phalanx. Can J Plast Surg (2004) 0.75

Knowledge, attitudes, and practices (KAP) survey based on two pilot-tested, self-administered questionnaires administered to consenting faculty and resident participants and retrieved in a sealed, anonymized envelope. J Surg Educ (2010) 0.75

Identifying causes for high readmission rates after stoma reversal. Surg Endosc (2013) 0.75

Role of primary healthcare and innovative strategies in improving knowledge and practice of mothers regarding diarrhoeal diseases in a squatter settlement of Karachi. J Coll Physicians Surg Pak (2005) 0.75